Upregulation of NPAS2, an alternative heterodimer to the BMAL1 partner, in some HCC tumors is associated with enhanced expression of CDC25A, which dephosphorylates cyclin-dependent kinases, promoting cell proliferation and inhibiting mitochondria-dependent intrinsic apoptosis. This evidence concerns the gene NPAS2 and hepatocellular carcinoma.